A systematic review of the effects of impaired glucose tolerance (IGT) on the incidence of chronic kidney disease (CKD) in young adults

Ferozkhan Jadhakhan, Tom Marshall, Paramjit Gill

Abstract


Objective: The risk of chronic kidney disease (CKD) is elevated in patients with diabetes mellitus but the effect of impaired glucose tolerance (IGT) is not known. This systematic review investigates the risk of CKD associated with IGT in young adults aged 18–40 years.

Methods: CINAHL, EMBASE, MEDLINE, PubMed, Cochrane libraries and grey literature were searched from inception to January 2015 without language restriction for case-control and cohort studies comparing the frequency of CKD in cases aged 18–40 years with IGT/IFG (impaired fasting glucose) with controls without glycaemic abnormality or with type 2 diabetes (T2DM). CKD outcomes were determined by: estimated glomerular filtration rate, albumin creatinine ratio, proteinuria ≥1, serum creatinine, protein creatinine ratio and creatinine clearance levels.

Results: Initial searches identified 90 citations potentially meeting the inclusion criteria. After full text review, 19 cohort studies and no case-control studies met the inclusion criteria, but only one cohort study reported separate data for persons aged 18–40 years. This study only compared the incidence of CKD in individuals with IGT with those with T2DM. The annual incidence of CKD was 0.13% per person-year compared with 2.4% in patients with T2DM.

Conclusion: The results of this systematic review demonstrate that the risk of CKD in young adults with IGT/IFG is lacking. Further research is needed to estimate the incidence of CKD in this cohort of individuals. To bridge this gap in evidence, large epidemiological databases may be examined to quantify the risk of CKD in young adults aged 18–40 years with IGT/IFG compared with those with normoglycaemia. Data from these databases may potentially inform a prognostic study which may be useful in understanding the course and factors associated with CKD development. Finally, the results may emphasise the importance of identifying individuals with IGT/IFG earlier and implementing interventions to prevent or delay the development of CKD.

Keywords


impaired glucose tolerance, chronic kidney disease, estimated glomerular filtration rate, albumin creatinine ratio, type 2 diabetes

Full Text:

HTML PDF

References


 Levey A, Coresh J, Balk E, Kausz A, Levin A, Steffes M. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47. http://dx.doi.org/10.7326/0003-4819-139-2-200307150-00013

 Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 2010;11:49. http://dx.doi.org/10.1186/1471-2296-11-49

 Unwin N, Shaw J, Zimmet P, Alberti K. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-23. http://dx.doi.org/10.1046/j.1464-5491.2002.00835.x

 Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 2005;28:2436-40. http://dx.doi.org/10.2337/diacare.28.10.2436

 Tapp R, Shaw J, Zimmet P, Balkau B, Chadban S, Tonkin A. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Am J Kidney Dis 2004;44:792-8. http://dx.doi.org/10.1016/S0272-6386(04)01079-0

 Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. https://doi.org/10.1136/bmj.b2700

 Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-12. http://dx.doi.org/10.1001/jama.283.15.2008

 Jadhakhan F, Marshall T, Gill P. A systematic review investigating the cumulative incidence of chronic kidney disease in young adults with impaired glucose tolerance. Syst Rev 2015;4:69. http://dx.doi.org/10.1186/s13643-015-0059-6

 Buysschaert M, Bergman M. Definition of prediabetes. Med Clin North Am 2011;95:289-97, vii. http://dx.doi.org/10.1016/j.mcna.2010.11.002

 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9. http://dx.doi.org/10.2337/dc10-S062

 Hartling L, Milne A, Hamm M, Vandermeer B, Ansari M, Tsertsvadze A. Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. J Clin Epidemiol 2013;66:982-93. http://dx.doi.org/10.1016/j.jclinepi.2013.03.003

 Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:D5928. http://dx.doi.org/10.1136/bmj.d5928

 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101. http://dx.doi.org/10.2307/2533446

 Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 1997;315:629-34. http://dx.doi.org/10.1136/bmj.315.7109.629

 Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29. http://dx.doi.org/10.1016/S0895-4356(00) 00242-0

 Kim NH, Pavkov ME, Knowler WC, et al. Predictive value of albuminuria in American Indian youth with or without type 2 diabetes. Pediatrics 2010;125:e844–51. http://dx.doi.org/10.1542/peds.2009-1230

 Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996;335:1636-42. http://dx.doi.org/10.1056/NEJM199611283352203

 Meigs JB, D'Agostino RB Sr, Nathan DM, Rifai N, Wilson PW. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care 2002;25:977-83. http://dx.doi.org/10.2337/diacare.25.6.977

 Nelson RG, Tan M, Beck GJ, et al. Changing glomerular filtration with progression from impaired glucose tolerance to type II diabetes mellitus. Diabetologia 1999;42:90-3. http://dx.doi.org/10.1007/s001250051118

 Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989;32:870-6. http://dx.doi.org/10.1007/BF00297452

 Yokoyama H, Kanno S, Takahashi S, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol 2009;4:1432-40. http://dx.doi.org/10.2215/CJN.06511208

 Tozawa M, Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007;30:937-43. http://dx.doi.org/10.1291/hypres.30.937

 Nelson RG, Pettitt DJ, Baird HR, et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993;36:998-1001. http://dx.doi.org/10.1007/BF02374490

 Rashidi A, Ghanbarian A, Azizi F. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2007;2:976-83. http://dx.doi.org/10.2215/CJN.01020207

 Kitiyakara C, Yamwong S, Cheepudomwit S, et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007;71:693-700. http://dx.doi.org/10.1038/sj.ki.5002128

 Sun F, Tao Q, Zhan S. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort. Nephrology 2010;15:84-92. http://dx.doi.org/10.1111/j.1440-1797.2009.01150.x

 Yang T, Chu CH, Hsu CH, et al. Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study. Nephrology 2012;17:532-8. http://dx.doi.org/10.1111/j.1440-1797.2012.01607.x

 Kovács T, Vas T, Kovesdy CP, et al. Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy. Clin Kidney J 2013;6:395-401. http://dx.doi.org/10.1093/ckj/sfs131

 Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes Metab Res Rev 2010;26: 26-32. http://dx.doi.org/10.1002/dmrr.1058

 Ryu S, Chang Y, Woo HY, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009;53:59-69. http://dx.doi.org/10.1053/j.ajkd.2008.07.027

 Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 2005;165:2299-304. http://dx.doi.org/10.1001/archinte.165.19.2299

 Tohidi M, Hasheminia M, Mohebi R, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PloS One 2012;7:e45304. http://dx.doi.org/10.1371/journal.pone.0045304

 Iseki K, Ikemiya Y, Kinjo K, Iseki C, Takishita S. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan. Clin Exp Nephrol 2004;8:250-6. http://dx.doi.org/10.1007/s10157-004-0293-z




DOI: https://doi.org/10.15277/bjd.2016.105

Refbacks

  • There are currently no refbacks.


The Journal of the Association of British Clinical Diabetologists